Endurance RP Ltd

Regent Pacific Group Limited is an investment holding company focused on healthcare and life sciences in the United States, Europe, and Asia Pacific. It operates through two segments: Biopharma and Corporate Investment. The Biopharma segment engages in research, development, manufacturing, marketing, and sale of pharmaceutical products for urological disorders, and develops an AI system for biological aging clocks across molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities and provides management services. Formerly known as Endurance RP Limited, it changed its name to Regent Pacific Group Limited in July 2023. Founded in 1991, it is headquartered in Central, Hong Kong.